Amyloidosis Organ Involvement Score

Score organ involvement in systemic amyloidosis (AL, ATTR, AA) using biomarkers and clinical criteria to stratify prognosis and guide treatment intensity.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Score organ involvement in systemic amyloidosis (AL, ATTR, AA) using biomarkers and clinical criteria to stratify prognosis and guide treatment intensity

Each component has a specific meaning:

  • Biomarkers — The biomarkers recorded for the scenario being assessed.
  • Clinical criteria — The clinical criteria recorded for the scenario being assessed.

Note: Interpret the amyloidosis organ score result against the thresholds and context described above.

How to Use

Enter the biomarkers, clinical criteria for the scenario you are assessing. Score organ involvement in systemic amyloidosis (AL, ATTR, AA) using biomarkers and clinical criteria to stratify prognosis and guide treatment intensity. Use the amyloidosis organ score result to inform your calculation.

Frequently Asked Questions